See as well Our reference tools Ebola: external links
DEFINITION OF AN EVD
Case an investigation
- Fever of >38.0 ˚C objectified or not OR
- Symptoms consistent with EVD (such as: diarrhea, vomiting, bleeding) OR a combination of non-specific symptoms (such as: fatigue, weakness, headache, abdominal pain, myalgia, arthralgia, etc.). ET
- Epidemiological risk factors: having, during the 21 days preceding the onset of symptoms, stayed in an area where Ebola virus transmission is active (Guinea, Liberia, Sierra Leone).
Confirmed case
- After investigation, a case with a confirmed diagnosis of Ebola virus infection by the Laboratoire de Santé Publique du Québec (LSPQ).
TRANSMISSION MODE
- Direct contact (injured skin or mucous membranes) with blood, biological fluids, secretions or excretions (eg stools, vomiting, urine, sweat, saliva, semen, breast milk, tears, etc.) of an infected person (alive or deceased).
- Indirect contact with objects, surfaces, clothing or bedding contaminated with blood, body fluids, secretions or excretions of an infected person (living or dead).
- Possibly by opportunistic airborne route, in case of lung involvement and when performing aerosol-generating procedures.
INCUBATION PERIOD
From 2 to 21 days with an average of 4 to 10 days.
CONTAGIOSITY
As soon as symptoms appear. Increase in contagiousness with the progression of the disease, particularly with the occurrence of digestive manifestations.
*A patient who does not show symptoms is not contagious.
PREVENTION AND CONTROL MEASURE FOR HOSPITALS:
Consult the INSPQ document: https://www.inspq.qc.ca/
Chat pre transfer
Phone number CCAR telephone exchange: 514-345-4931 then 4992
Discuss with the head of infectious diseases and the emergency physician
N Desmarais (infection prevention), C Laferrière (Microbiology), V Lamarre (Infectious Diseases)
Online October 2015
